SCHEMBL8768476

SCHEMBL8768476

O=C(O)c1ccccc1CO.[NaH]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 2/20 0.59
ALDH1A1 P00352 4/20 0.56
ALOX15 P16050 1/20 0.56
HPGD P15428 2/20 0.56
GAA P10253 2/20 0.56
LMNA P02545 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
TSHR P16473 1/20 0.53
NR4A1 P22736 1/20 0.48
NR4A2 P43354 1/20 0.48
NR4A3 Q92570 1/20 0.48
KDM4E B2RXH2 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
HMGB1 P09429 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
CA7 P43166 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL374696 0.98 FOLH1 (0.61) FOLH1ALDH1A1ALOX15HPGDGAA
SCHEMBL6043201 0.95 FOLH1 (0.59) FOLH1ALDH1A1ALOX15HPGDGAA
Succinic Acid SCHEMBL6229447 0.90 FOLH1 (0.53) FOLH1ALDH1A1ALOX15HPGDGAA
Terephthalic Acid SCHEMBL27748404 0.90 TSHR (0.68) FOLH1ALDH1A1ALOX15HPGDGAA
Toluene SCHEMBL27935612 0.88 FOLH1 (0.52) FOLH1ALDH1A1ALOX15HPGDGAA
SCHEMBL821015 0.86 FOLH1 (0.50) FOLH1ALDH1A1ALOX15HPGDGAA
4-Methylbenzoic Acid SCHEMBL7897437 0.82 TSHR (0.58) FOLH1ALDH1A1ALOX15HPGDGAA
SCHEMBL70392 0.81 FOLH1 (0.76) FOLH1ALDH1A1ALOX15HPGDGAA
SCHEMBL9668760 0.81 GAA (0.55) FOLH1ALDH1A1ALOX15HPGDGAA
SCHEMBL30365583 0.81 FOLH1 (0.76) FOLH1ALDH1A1ALOX15HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104945500-B Mixing agonist based on GIP is for treating metabolic disorder and obesity 印第安纳大学研究及科技有限公司 2019-07-09 CN disclosed
CN-102123723-B Glucagon/GLP-1 receptor co-agonists INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. (US) 2016-05-25 CN disclosed
CN-104945500-A GIP-based mixed agonists for treatment of metabolic disorders and obesity UNIV INDIANA RES & TECH CORP 2015-09-30 CN disclosed
CN-102105159-B GIP-based mixed agonists for the treatment of metabolic disorders and obesity UNIV INDIANA RES & TECH CORP 2015-07-08 CN disclosed
CN-103641907-A Glucagon/glp-1 receptor co-agonists UNIV INDIANA RES & TECH CORP 2014-03-19 CN disclosed
CN-102123723-A Glucagon/GLP-1 receptor co-agonists UNIV INDIANA RES & TECH CORP 2011-07-13 CN disclosed
CN-102105159-A GIP-based mixed agonists for the treatment of metabolic disorders and obesity UNIV INDIANA RES & TECH CORP 2011-06-22 CN disclosed
CN-1112180-C Pharmaceutical composition containing drug/beta-cyclodextrin complex in combination with acid-base couple SMIHKLINE BEECHAM PLC (GB) 2003-06-25 CN disclosed
EP-0547825-B1 Process for producing alpha-ketoamide derivative SHIONOGI & CO (JP) 1997-09-03 EP disclosed
CN-1133006-A Pharmaceutical composition containing drug/beta-cyclodextrin complex in combination with acid-base couple SMITHKLINE BEECHAM PLC (GB) 1996-10-09 CN disclosed
US-5414122-A Process for producing alpha-ketoamide derivative SHIONOGI & CO., LTD. (JP) 1995-05-09 US disclosed
US-5258551-A Amidation of benzoyl halide derivative with organic isocyanide; fungicide intermediates SHIONOGI & CO., LTD. (JP) 1993-11-02 US disclosed
EP-0547825-A2 Process for producing alpha-ketoamide derivative SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) 1993-06-23 EP disclosed